SHOP APOTHEKE EUROPE N.V.

  • WKN: A2AR94
  • ISIN: NL0012044747
  • Land: Niederlande

Nachricht vom 12.01.2018 | 16:25

DGAP-DD: SHOP APOTHEKE EUROPE N.V. english


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

12.01.2018 / 16:24
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Name and legal form: Koehler Invest N.V.

2. Reason for the notification

a) Position / status
Person closely associated with:
Title:
First name: Michael Stephan Rolf
Last name(s): Köhler
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
SHOP APOTHEKE EUROPE N.V.

b) LEI
529900JK6UXHY1YKZ082 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: NL0012044747

b) Nature of the transaction
Acquisition

c) Price(s) and volume(s)
Price(s) Volume(s)
46.1000 EUR 645.40 EUR
46.1000 EUR 368.80 EUR
46.1000 EUR 2489.40 EUR
46.1000 EUR 2489.40 EUR
46.1000 EUR 4932.70 EUR
46.1000 EUR 3319.20 EUR
46.1000 EUR 1521.30 EUR
46.2000 EUR 6560.40 EUR
46.3000 EUR 92600.00 EUR
46.2000 EUR 85839.60 EUR
46.1000 EUR 30333.80 EUR

d) Aggregated information
Price Aggregated volume
46.2200 EUR 231100.0000 EUR

e) Date of the transaction
2018-01-10; UTC+1

f) Place of the transaction
Name: XETRA
MIC: XETR



12.01.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

News im Fokus

BASF SE: Ergebnis steigt im Geschäftsjahr 2017 deutlich und übertrifft Analystenschätzungen erheblich

18. Januar 2018, 16:49

Aktuelle Research-Studie

Original-Research: PHARMING (von First Berlin Equity Research GmbH): BUY PHARMING

18. Januar 2018